Strategies in the design of nanoparticles for therapeutic applications
Abstract
Engineered nanoparticles have the potential to revolutionize the diagnosis and treatment of many diseases; for example, by allowing the targeted delivery of a drug to particular subsets of cells. However, so far, such nanoparticles have not proved capable of surmounting all of the biological barriers required to achieve this goal. Nevertheless, advances in nanoparticle engineering, as well as advances in understanding the importance of nanoparticle characteristics such as size, shape and surface properties for biological interactions, are creating new opportunities for the development of nanoparticles for therapeutic applications. This Review focuses on recent progress important for the rational design of such nanoparticles and discusses the challenges to realizing the potential of nanoparticles.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Liposomes application and lipid-based drug delivery systems have been narrowed due to attained drug resistance and poor targeting.
“Nevertheless, liposomes application and lipid-based drug delivery systems have been narrowed due to attained drug resistance and poor targeting [98,99].”
From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [98]
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,771 · see citing works
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282 · see citing works
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664 · see citing works
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476 · see citing works
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233 · see citing works
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,816 · see citing works
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2748 · Cited by 3,721 · see citing works
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699 · see citing works
Pierschbacher, M. D., & Ruoslahti, E. I. (1984) · Nature · doi:10.1038/309030a0 · Cited by 3,670 · see citing works
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637 · see citing works
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,521 · see citing works
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,364 · see citing works
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V. S., Torchilin, V. P., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,924 · see citing works
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918 · see citing works
Self-citationRejman, J., Oberle, V., Zuhorn, I. S., & Hoekstra, D. (2004) · Biochemical Journal · doi:10.1042/bj20031253 · Cited by 2,872 · see citing works
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J. M., Wang, A. Z., Langer, R., & Farokhzad, O. C. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,685 · see citing works
Shape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565 · see citing works
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D. B., Tolcher, A. W., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,508 · see citing works
Gradishar, W. J., Tjulandin, S., Davidson, N. G. P., Shaw, H., Desai, N. P., Bhar, P., Hawkins, M., & O’Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,159 · see citing works
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,157 · see citing works
Role of target geometry in phagocytosis
Champion, J. A., & Mitragotri, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600997103 · Cited by 2,082 · see citing works
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,030 · see citing works
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1958 · Cited by 1,956 · see citing works
Immunological properties of engineered nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823 · see citing works
Bangham, A. D., & Horne, R. W. (1964) · Journal of Molecular Biology · doi:10.1016/s0022-2836(64)80115-7 · Cited by 1,810 · see citing works
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon‐Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,732 · see citing works
PEGylated nanoparticles for biological and pharmaceutical applications
Otsuka, H., Nagasaki, Y., & Kataoka, K. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00226-0 · Cited by 1,587 · see citing works
Nanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,549 · see citing works
Physical approaches to biomaterial design
Mitragotri, S., & Lahann, J. (2009) · Nature Materials · doi:10.1038/nmat2344 · Cited by 1,445 · see citing works
Saito, G., Swanson, J. A., & Lee, K.-D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00179-5 · Cited by 1,407 · see citing works
Brem, H., Piantadosi, S., Burger, P. C., Walker, M., Selker, R. G., Vick, N. A., Black, K. L., Sisti, M. B., Brem, S. S., Mohr, G., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90755-6 · Cited by 1,390 · see citing works
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., & Papahadjopoulos, D. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01426-1 · Cited by 1,265 · see citing works
Particle shape: A new design parameter for micro- and nanoscale drug delivery carriers
Champion, J. A., Katare, Y. K., & Mitragotri, S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.022 · Cited by 1,207 · see citing works
Low, P. S., Henne, W. A., & Doorneweerd, D. D. (2007) · Accounts of Chemical Research · doi:10.1021/ar7000815 · Cited by 1,174 · see citing works
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., & Ruoslahti, E. I. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.013 · Cited by 1,140 · see citing works
Reduction-sensitive polymers and bioconjugates for biomedical applications
Meng, F., Hennink, W. E., & Zhong, Z. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.026 · Cited by 1,132 · see citing works
Structure and properties of pharmacologically active polymers
Ringsdorf, H. (1975) · Journal of Polymer Science: Polymer Symposia · doi:10.1002/polc.5070510111 · Cited by 1,094 · see citing works
Amphiphilic block copolymers for drug delivery
Adams, M. L., Lavasanifar, A., & Kwon, G. S. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10397 · Cited by 1,078 · see citing works
Endocytic mechanisms for targeted drug delivery☆
Bareford, L. M., & Swaan, P. W. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.008 · Cited by 1,035 · see citing works
Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody
Miller, R. A., Maloney, D. G., Warnke, R. A., & Levy, R. (1982) · New England Journal of Medicine · doi:10.1056/nejm198203043060906 · Cited by 985 · see citing works
Davis, M. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900015y · Cited by 979 · see citing works
Size and shape effects in the biodistribution of intravascularly injected particles
Decuzzi, P., Godin, B., Tanaka, T., Lee, S., Chiappini, C., Liu, X., & Mauro Ferrari, B. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.014 · Cited by 968 · see citing works
Kukowska‐Latallo, J. F., Candido, K. A., Cao, Z., Nigavekar, S. S., Majoros, I., Thomas, T. P., Balogh, L. P., Khan, M. K., & Baker, J. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3921 · Cited by 912 · see citing works
Transport of molecules across tumor vasculature
Jain, R. K. (1987) · Cancer and Metastasis Reviews · doi:10.1007/bf00047468 · Cited by 869 · see citing works
Direct Fabrication and Harvesting of Monodisperse, Shape-Specific Nanobiomaterials
Rolland, J. P., Maynor, B. W., Euliss, L. E., Exner, A. E., Rothrock, G. D., & DeSimone, J. M. (2005) · Journal of the American Chemical Society · doi:10.1021/ja051977c · Cited by 849 · see citing works
Self-citationTargeting of drugs and nanoparticles to tumors
Ruoslahti, E. I., Bhatia, S. N., & Sailor, M. J. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200910104 · Cited by 833 · see citing works
Kim, T.-Y., Kim, D.-W., Chung, J.-Y., Shin, S. G., Kim, S.-C., Heo, D. S., Kim, N. K., & Bang, Y.-J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0655 · Cited by 821 · see citing works
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
Sinha, R., Gloria, K., Nie, S., & Shin, D. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0141 · Cited by 802 · see citing works
Surface Chemistry Influences Implant Biocompatibility
Tang, L., Thevenot, P., & Hu, W. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608783790901 · Cited by 800 · see citing works
Nuclear Pore Complex Is Able to Transport Macromolecules with Diameters of ∼39 nm
Panté, N., & Kann, M. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-06-0308 · Cited by 778 · see citing works
Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells
Vinogradov, S. V., Bronich, T. K., & Kabanov, A. V. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00245-9 · Cited by 776 · see citing works
Targeted pharmaceutical nanocarriers for cancer therapy and imaging
Torchilin, V. P. (2007) · The AAPS Journal · doi:10.1208/aapsj0902015 · Cited by 758 · see citing works
Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
Choi, C. H. J., Alabi, C. A., Webster, P. C., & Davis, M. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914140107 · Cited by 699 · see citing works
Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization
Fukumura, D., & Jain, R. K. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.05.003 · Cited by 699 · see citing works
Vasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689 · see citing works
Lee, C., Gillies, E. R., Fox, M. E., Guillaudeu, S. J., Fréchet, J. M. J., Dy, E. E., & Szoka, F. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607705103 · Cited by 648 · see citing works
Nanoparticles for drug delivery to the lungs
Sung, J. C., Pulliam, B., & Edwards, D. A. (2007) · Trends in biotechnology · doi:10.1016/j.tibtech.2007.09.005 · Cited by 644 · see citing works
Daniels‐Wells, T. R., Delgado, T., Rodríguez, J. A., Helguera, G. F., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.010 · Cited by 630 · see citing works
Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?
Decuzzi, P., Pasqualini, R., Arap, W., & Mauro Ferrari, B. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9697-x · Cited by 618 · see citing works
Shape Induced Inhibition of Phagocytosis of Polymer Particles
Champion, J. A., & Mitragotri, S. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9626-z · Cited by 618 · see citing works
Neri, D., & Bicknell, R. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1627 · Cited by 599 · see citing works
HPMA copolymers: Origins, early developments, present, and future☆
Kopec̆ek, J., & Kopečková, P. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.004 · Cited by 576 · see citing works
Muro, S., Garnacho, C., Champion, J. A., Leferovich, J. M., Gajewski, C., Schuchman, E. H., Mitragotri, S., & Muzykantov, V. R. (2008) · Molecular Therapy · doi:10.1038/mt.2008.127 · Cited by 564 · see citing works
Lee, K. S., Chung, H. C., Im, S. A., Park, Y. H., Kim, C. S., Kim, S.-B., Rha, S. Y., Lee, M. Y., & Ro, J. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9591-y · Cited by 541 · see citing works
Nanoparticles—a historical perspective
Kreuter, J. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.021 · Cited by 540 · see citing works
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Aa, I. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 538 · see citing works
Biodegradable nanoparticles for cytosolic delivery of therapeutics
VASIR, J., & LABHASETWAR, V (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.003 · Cited by 526 · see citing works
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
Daniels‐Wells, T. R., Delgado, T., Helguera, G. F., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.006 · Cited by 519 · see citing works
Gary, D. J., Puri, N., & Won, Y. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.021 · Cited by 514 · see citing works
The role of complement in inflammation and phagocytosis
Frank, M. M., & Fries, L. F. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90009-i · Cited by 504 · see citing works
Which polymers can make nanoparticulate drug carriers long-circulating?
Torchilin, V. P., & Trubetskoy, V. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00022-y · Cited by 480 · see citing works
Biomimetic amplification of nanoparticle homing to tumors
Simberg, D., Duza, T., Park, J. H., Essler, M., Pilch, J., Zhang, L., Derfus, A. M., Yang, M., Hoffman, R. M., Bhatia, S. N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610298104 · Cited by 473 · see citing works
Oh, J. K., Siegwart, D. J., Lee, H., Sherwood, G. A., Peteanu, L. A., Hollinger, J. O., Kataoka, K., & Matyjaszewski, K. A. (2007) · Journal of the American Chemical Society · doi:10.1021/ja069150l · Cited by 467 · see citing works
Prostate-specific membrane antigen is produced in tumor-associated neovasculature.
Chang, S. S., O’Keefe, D. S., Bacich, D. J., Reuter, V. E., Heston, W. D. W., & Gaudin, P. B. (1999) · PubMed · Cited by 465 · see citing works
Gabizon, A. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.011 · Cited by 464 · see citing works
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Murphy, E. A., Majeti, B. K., Barnes, L. A., Makale, M., Weis, S. M., Lutu-Fuga, K. M., Wrasidlo, W., & Cheresh, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803728105 · Cited by 454 · see citing works
Solvent-Resistant Photocurable “Liquid Teflon” for Microfluidic Device Fabrication
Rolland, J. P., van Dam, R. M., Schorzman, D. A., Quake, S. R., & DeSimone, J. M. (2004) · Journal of the American Chemical Society · doi:10.1021/ja031657y · Cited by 440 · see citing works
Self-citationHepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., Hesslewood, S., Julyan, P. J., Poyner, R., Doran, J., Young, A., Burtles, S. S., & Kerr, D. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1668 · Cited by 435 · see citing works
Dendrimer-platinate: a novel approach to cancer chemotherapy.
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · PubMed · Cited by 417 · see citing works
Gregoriadis, G. C. (1973) · FEBS Letters · doi:10.1016/0014-5793(73)80394-1 · Cited by 414 · see citing works
Cell surface tumor endothelial markers are conserved in mice and humans.
Carson-Walter, E. B., Watkins, D. N., Nanda, A., Vogelstein, B., Kinzler, K. W., & Croix, B. S. (2001) · PubMed · Cited by 410 · see citing works
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199909000-00010 · Cited by 402 · see citing works
Imparting size, shape, and composition control of materials for nanomedicine
Euliss, L. E., DuPont, J. A., Gratton, S. E. A., et al. (2006) · Chemical Society Reviews · doi:10.1039/b600913c · Cited by 383 · see citing works
Danson, S., Ferry, D., Alakhov, V, Margison, J., Kerr, D., Jowle, D., Brampton, M., Halbert, G., & Ranson, M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601856 · Cited by 382 · see citing works
The use of silicone rubber as a carrier for prolonged drug therapy
Folkman, J., & Long, D. M. (1964) · Journal of Surgical Research · doi:10.1016/s0022-4804(64)80040-8 · Cited by 368 · see citing works
Wang, Y.-X., Robertson, J. L., Spillman, W. B., & Claus, R. O. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036909.41843.18 · Cited by 357 · see citing works
The folate receptor: What does it promise in tissue-targeted therapeutics?
Salazar, M. D., & Ratnam, M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9048-0 · Cited by 350 · see citing works
PEGylated PLGA nanoparticles for the improved delivery of doxorubicin
Park, J. Y., Fong, P., Lu, J., Russell, K. S., Booth, C. J., Saltzman, W. M., & Fahmy, T. M. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.02.002 · Cited by 339 · see citing works
Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel
Danhier, F., Vroman, B., Lecouturier, N., Crokart, N., Pourcelle, V., Freichels, H., Jérôme, C., Marchand‐Brynaert, J., Féron, O., & Véronique Préat, A. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.011 · Cited by 335 · see citing works
Ahmed, F., Pakunlu, R. I., Srinivas, G., Brannan, A. K., Bates, F. S., Klein, M. L., Minko, T., & Discher, D. E. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050103u · Cited by 330 · see citing works
Targeting Mitochondria with Organelle‐Specific Compounds: Strategies and Applications
Yousif, L. F., Stewart, K. M., & Kelley, S. O. (2009) · ChemBioChem · doi:10.1002/cbic.200900185 · Cited by 330 · see citing works
Roger, E., Lagarce, F., Garcion, E., & Benoît, J. (2010) · Nanomedicine · doi:10.2217/nnm.09.110 · Cited by 324 · see citing works
Göppert, T. M., & Müller, R. H. (2005) · Journal of drug targeting · doi:10.1080/10611860500071292 · Cited by 299 · see citing works
Stupack, D. G., & Cheresh, D. A. (2004) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)64009-9 · Cited by 297 · see citing works
Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.6.1668 · Cited by 287 · see citing works
From Combinatorial Chemistry to Cancer-Targeting Peptides
Aina, O. H., Liu, R., Sutcliffe-Goulden, J., Mařı́k, J., Pan, C.-X., & Lam, K. S. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700073y · Cited by 285 · see citing works
Torchilin, V. P. (2008) · Peptide Science · doi:10.1002/bip.20989 · Cited by 283 · see citing works
Gratton, S. E. A., Pohlhaus, P. D., Lee, J., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.027 · Cited by 266 · see citing works
Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows
Lee, S., Mauro Ferrari, B., & Decuzzi, P. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/49/495101 · Cited by 259 · see citing works
Yamada, Y., & Harashima, H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.04.016 · Cited by 258 · see citing works
Ilium, L., Davis, S. S., Wilson, C. G., et al. (1982) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(82)90113-2 · Cited by 254 · see citing works
Spatiotemporal controlled delivery of nanoparticles to injured vasculature
Chan, J. M., Zhang, L., Tong, R., Ghosh, D., Gao, W., Liao, G., Yuet, K. P., Gray, D. S., Rhee, J., Cheng, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914585107 · Cited by 253 · see citing works
Wong, J., Brugger, A. M., Khare, A. R., Chaubal, M. V., Papadopoulos, P., Rabinow, B. E., Kipp, J., & Ning, J. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.008 · Cited by 251 · see citing works
Patri, A. K., Myc, A., Beals, J. L., et al. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0499127 · Cited by 249 · see citing works
Targeted delivery to the nucleus☆
Pouton, C. W., Wagstaff, K. M., ROTH, D., Moseley, G. W., & Jans, D. A. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.010 · Cited by 246 · see citing works
Moghimi, S. M., & Patel, H. M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00131-2 · Cited by 240 · see citing works
Berry, G. J., Billingham, M. E., Alderman, E. L., Richardson, P., Torti, F. M., Lum, B. L., Patek, A., & Martin, F. J. (1998) · Annals of Oncology · doi:10.1023/a:1008216430806 · Cited by 240 · see citing works
Designer Biomaterials for Nanomedicine
Doshi, N., & Mitragotri, S. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200901538 · Cited by 238 · see citing works
Boddapati, S. V., D’Souza, G. G. M., Erdoğan, S., Torchilin, V. P., & Weissig, V. (2008) · Nano Letters · doi:10.1021/nl801908y · Cited by 234 · see citing works
Merkel, T. J., Herlihy, K. P., Nunes, J. K., Orgel, R. M., Rolland, J. P., & DeSimone, J. M. (2009) · Langmuir · doi:10.1021/la903890h · Cited by 229 · see citing works
Self-citationIntracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy
Misra, R., & Sahoo, S. K. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.11.010 · Cited by 218 · see citing works
Milowsky, M. I., Nanus, D. M., Kostakoğlu, L., Sheehan, C. E., Vallabhajosula, S., Goldsmith, S. J., Ross, J. S., & Bander, N. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.8097 · Cited by 218 · see citing works
Polymers and nanoparticles: Intelligent tools for intracellular targeting?
Breunig, M., Bauer, S., & Göpferich, A. M. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.06.010 · Cited by 215 · see citing works
Quantum Dots Targeted to the Assigned Organelle in Living Cells
Hoshino, A., Fujioka, K., Oku, T., et al. (2004) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2004.tb03621.x · Cited by 210 · see citing works
Albumin microspheres for study of the reticuloendothelial system.
Scheffel, U., Rhodes, B. A., Natarajan, T. K., & Wagner, H. N. (1972) · PubMed · Cited by 207 · see citing works
Kirpotin, D. B., Hong, K., Mullah, N. N., Papahadjopoulos, D., & Zalipsky, S. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00521-2 · Cited by 206 · see citing works
PEGylation of Nanocarrier Drug Delivery Systems: State of the Art
Howard, M. D., Jay, M., Dziubla, T. D., & Lü, X. (2008) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2008.021 · Cited by 203 · see citing works
Albumin Microspheres as Vehicles for Achieving Specificity in Drug Delivery
Kramer, P. A. (1974) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600631044 · Cited by 202 · see citing works
Moghimi, S. M., Hamad, I. M., Andresen, T. L., Jørgensen, K., & Szebeni, J. (2006) · The FASEB Journal · doi:10.1096/fj.06-6186fje · Cited by 201 · see citing works
Development of Biodegradable and Injectable Latices for Controlled Release of Potent Drugs
Gurny, R., Peppas, N. A., Harrington, D. D., & Banker, G. S. (1981) · Drug Development and Industrial Pharmacy · doi:10.3109/03639048109055684 · Cited by 198 · see citing works
Polymeric nanovehicles for anticancer drugs with triggering release mechanisms
Oh, K. T., Yin, H., Lee, E. S., & Bae, Y. H. (2007) · Journal of Materials Chemistry · doi:10.1039/b707142f · Cited by 196 · see citing works
Ogawara, K., Furumoto, K., Nagayama, S., Minato, K., Higaki, K., Kai, T., & Kimura, T. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.028 · Cited by 195 · see citing works
Passirani, C., BARRATT, G. M., Devissaguet, J., & Labarre, D. (1998) · Pharmaceutical Research · doi:10.1023/a:1011930127562 · Cited by 179 · see citing works
Moghimi, S. M., Hedeman, H., Muir, I. S., Illum, L., & Davis, S. S. (1993) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(93)90105-h · Cited by 176 · see citing works
Porter, C. J. H., Moghimi, S. M., Illum, L., & Davis, S. S. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80655-z · Cited by 173 · see citing works
The EPR Effect and Polymeric Drugs: A Paradigm Shift for Cancer Chemotherapy in the 21st Century
Maeda, H., Greish, K. F., & Fang, J. Q. (2005) · Advances in polymer science · doi:10.1007/12_026 · Cited by 173 · see citing works
Importins and Beyond: Non‐Conventional Nuclear Transport Mechanisms
Wagstaff, K. M., & Jans, D. A. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00937.x · Cited by 169 · see citing works
Wang, X., Li, J., Wang, Y., Cho, K.-J., Gloria, K., Gjyrezi, A., Koenig, L., Giannakakou, P., Shin, H. J. C., Tighiouart, M., et al. (2009) · ACS Nano · doi:10.1021/nn900649v · Cited by 165 · see citing works
Cardiac safety of liposomal anthracyclines
Ewer, M. S., Martin, F. J., Henderson, I. C., Shapiro, C. L., Benjamin, R. S., & Gabizón, A. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.08.006 · Cited by 162 · see citing works
Imaging angiogenesis and the microenvironment
Fukumura, D., & JAIN, R. K. (2008) · Apmis · doi:10.1111/j.1600-0463.2008.01148.x · Cited by 162 · see citing works
Biomimetic Nanocarrier for Direct Cytosolic Drug Delivery
Zhang, Z., Cao, W., Jin, H., Lovell, J. F., Yang, M., Ding, L., Chen, J., Corbin, I. R., Luo, Q., & Zheng, G. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200903112 · Cited by 159 · see citing works
Jatzkewitz, H. (1955) · Zeitschrift für Naturforschung B · doi:10.1515/znb-1955-0106 · Cited by 154 · see citing works
Kattan, J. G., Droz, J., Couvreur, P., Marino, J. P., Boutan-Laroze, A., Rougier, P. R., Brault, P., Vranckx, H., Grognet, J., Morge, X., et al. (1992) · Investigational New Drugs · doi:10.1007/bf00877245 · Cited by 153 · see citing works
Shape-Specific, Monodisperse Nano-Molding of Protein Particles
Kelly, J. Y., & DeSimone, J. M. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8014428 · Cited by 143 · see citing works
Self-citationLim, W., Tan, E. H., Toh, C., Hee, S. W., Leong, S. S., Ang, P., Wong, N. S., & Chowbay, B. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp315 · Cited by 142 · see citing works
The Pursuit of a Scalable Nanofabrication Platform for Use in Material and Life Science Applications
Gratton, S. E. A., Williams, S., Napier, M. E., Pohlhaus, P. D., Zhou, Z., Wiles, K. B., Maynor, B. W., Shen, C. K.-F., Olafsen, T., Samulski, E. T., et al. (2008) · Accounts of Chemical Research · doi:10.1021/ar8000348 · Cited by 142 · see citing works
Self-citationReductively Labile PRINT Particles for the Delivery of Doxorubicin to HeLa Cells
Petros, R. A., Ropp, P. A., & DeSimone, J. M. (2008) · Journal of the American Chemical Society · doi:10.1021/ja801436j · Cited by 137 · see citing works
Self-citationDNA delivery systems based on complexes of DNA with synthetic polycations and their copolymers
Oupický, D., Koňák, Č., Ulbrich, K., et al. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00249-7 · Cited by 130 · see citing works
Biocompatibility of a Biodegradable, Controlled-Release Polymer in the Rabbit Brain
Brem, H., KADER, A., Epstein, J. I., Tamargo, R. J., Domb, A. J., Langer, R., & Leong, K. W. (1989) · Selective Cancer Therapeutics · doi:10.1089/sct.1989.5.55 · Cited by 130 · see citing works
Biologically Active Synthetic Polymers
Breslow, D. S. (1976) · Pure and Applied Chemistry · doi:10.1351/pac197646020103 · Cited by 128 · see citing works
Hamad, I. M., Hunter, A. C., Rutt, K. J., Liu, Z., Dai, H., & Moghimi, S. M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.05.020 · Cited by 122 · see citing works
Designing polymer conjugates as lysosomotropic nanomedicines
Duncan, R. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350056 · Cited by 117 · see citing works
Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice
Oldenborg, P. (2002) · Blood · doi:10.1182/blood.v99.10.3500 · Cited by 108 · see citing works
Liposomes as targeted drug delivery systems in the treatment of breast cancer
Sharma, G., Anabousi, S., Ehrhardt, C., et al. (2006) · Journal of drug targeting · doi:10.1080/10611860600809112 · Cited by 103 · see citing works
Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection.
Moghimi, S. M., & Davis, S. S. (1994) · PubMed · Cited by 103 · see citing works
Down-Regulation of Basophil Function by Human CD200 and Human Herpesvirus-8 CD200
Shiratori, I., Yamaguchi, M., Suzukawa, M., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4441 · Cited by 101 · see citing works
Nanoparticle Drug Delivery Platform
Napier, M. E., & DeSimone, J. M. (2007) · Journal of macromolecular science. Part C, Reviews in macromolecular chemistry and physics/Journal of macromolecular science. Reviews in macromolecular chemistry and physics · doi:10.1080/15583720701454999 · Cited by 100 · see citing works
Self-citationCancer‐Cell‐Phenotype‐Dependent Differential Intracellular Trafficking of Unconjugated Quantum Dots
Barua, S., & Rege, K. (2008) · Small · doi:10.1002/smll.200800972 · Cited by 100 · see citing works
Gratton, S. E. A., Napier, M. E., Ropp, P. A., Tian, S., & DeSimone, J. M. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9654-8 · Cited by 98 · see citing works
Self-citationStructure, function and biological properties of integrin ?v?3on human melanoma cells
Cheresh, D. A. (1991) · Cancer and Metastasis Reviews · doi:10.1007/bf00046839 · Cited by 96 · see citing works
Souhami, R. L., Patel, H. M., & Ryman, B. E. (1981) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(81)90366-4 · Cited by 93 · see citing works
Using nuclear targeting signals to enhance non‐viral gene transfer
Chan, C., & Jans, D. A. (2002) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2002.01061.x · Cited by 89 · see citing works
Mitotic trafficking of silicon microparticles
Serda, R. E., Ferrati, S., Godin, B., et al. (2009) · Nanoscale · doi:10.1039/b9nr00138g · Cited by 88 · see citing works
Leu, D., Manthey, B., Kreuter, J., Speiser, P. P., & Delucax, P. P. (1984) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600731028 · Cited by 88 · see citing works
Effect of coupling of albumin onto surface of PEG liposome on its in vivo disposition
Furumoto, K., Yokoe, J.-I., Ogawara, K., AMANO, S., TAKAGUCHI, M., Higaki, K., Kai, T., & Kimura, T. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.026 · Cited by 79 · see citing works
Albumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in rats
YOKOE, J., SAKURAGI, S., YAMAMOTO, K., et al. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.008 · Cited by 78 · see citing works
Shepherd, P. L. (1983) · Gerontology & Geriatrics Education · doi:10.1300/j021v03n02_09 · Cited by 74 · see citing works
Lymphoma models for B cell activation and tolerance
Alés‐Martínez, J., Warner, G. L., & Scott, D. W. (1990) · Cellular Immunology · doi:10.1016/0008-8749(90)90153-i · Cited by 72 · see citing works
Chan, C.-K., Senden, T. J., & Jans, D. A. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301275 · Cited by 71 · see citing works
HPMA copolymers: 30years of advances☆
Lammers, T., & Ulbrich, K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.12.004 · Cited by 70 · see citing works
Schliemann, C., Roesli, C., Kamada, H., et al. (2009) · Blood · doi:10.1182/blood-2009-08-239004 · Cited by 64 · see citing works
Callahan, J., & Kopec̆ek, J. (2006) · Biomacromolecules · doi:10.1021/bm060336m · Cited by 63 · see citing works
Delivery of drugs and macromolecules to mitochondria☆
Mukhopadhyay, A., & Weiner, H. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.004 · Cited by 55 · see citing works
Renschler, M. F., Bhatt, R. R., Dower, W. J., et al. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3623 · Cited by 52 · see citing works
Über den Einbau physiologisch wirksamer Substanzen in ein kollodiales Blutplasma-Ersatzmittel
Jatzkewitz, H. (1954) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1954.297.1.149 · Cited by 52 · see citing works
Pennell, C. A., & Scott, D. W. (1986) · European Journal of Immunology · doi:10.1002/eji.1830161217 · Cited by 50 · see citing works
Jacobson, B. S., Stolz, D. B., & Schnitzer, J. E. (1996) · Nature Medicine · doi:10.1038/nm0496-482 · Cited by 48 · see citing works
Jatzkewitz, H. (1954) · PubMed · Cited by 38 · see citing works
Liposome disposition in vivo: effects of pre-dosing with lipsomes.
Abra, R. M., Bosworth, M. E., & Hunt, C. A. (1980) · PubMed · Cited by 36 · see citing works
Terlecky, S. R., & Koepke, J. I. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.005 · Cited by 30 · see citing works
Braun, K., Pipkorn, R., & Waldeck, W. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867054546672 · Cited by 27 · see citing works
Regelson, W. (1986) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391158600100109 · Cited by 26 · see citing works
Technology evaluation: gemtuzumab ozogamicin, Celltech Group.
Niculescu‐Duvaz, I. (2000) · PubMed · Cited by 24 · see citing works
(2011) · Advanced & emerging communications technologies/Advanced and emerging communications technologies series · doi:10.1201/b10981-2 · Cited by 20 · see citing works
Increase in the Vascular Residence Time of Propranolol-Loaded Nanoparticles Coated with Heparin
Socha, M., Lamprecht, A., Ghazouani, F. E., et al. (2008) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2008.081 · Cited by 14 · see citing works
The intracellular and nuclear‐targeted delivery of an antiandrogen drug by carrier peptides
Hodoniczky, J., Sims, C. G., Best, W. M., et al. (2008) · Biopolymers · doi:10.1002/bip.20986 · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Cellular uptake of nanoparticles: Journey inside the cell
Behzadi, S., Serpooshan, V., Tao, W., Hamaly, M. A., Alkawareek, M. Y., Dreaden, E. C., Brown, D., Alkilany, A. M., Farokhzad, O. C., & Mahmoudi, M. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00636a · Cited by 2,859 · see citing works
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164 · see citing works
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912 · see citing works
Delivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800 · see citing works
Nanoparticles in the clinic: an update
Anselmo, A. C., & Mitragotri, S. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10143 · Cited by 1,766 · see citing works
Design of polymeric nanoparticles for biomedical delivery applications
Elsabahy, M., & Wooley, K. L. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15327k · Cited by 1,717 · see citing works
Block copolymer micelles in nanomedicine applications
Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309 · see citing works
Anselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321 · see citing works
Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288 · see citing works
Duan, X., & Li, Y. (2013) · Small · doi:10.1002/smll.201201390 · Cited by 926 · see citing works
Photosensitizers with Aggregation‐Induced Emission: Materials and Biomedical Applications
Hu, F., Xu, S., & Liu, B. (2018) · Advanced Materials · doi:10.1002/adma.201801350 · Cited by 859 · see citing works
Enzyme-responsive nanoparticles for drug release and diagnostics
de la Rica, R., Aili, D., & Stevens, M. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.002 · Cited by 765 · see citing works
Johnsen, K. B., Gudbergsson, J. M., Skov, M. N., Pilgaard, L., Moos, T., & Duroux, M. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.04.005 · Cited by 704 · see citing works
Recent advances of cocktail chemotherapy by combination drug delivery systems
Hu, Q., Sun, W., Wang, C., & Gu, Z. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.022 · Cited by 625 · see citing works
Tailoring nanocarriers for intracellular protein delivery
Gu, Z., Biswas, A., Zhao, M., & Tang, Y. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00227e · Cited by 543 · see citing works
Strategies to improve micelle stability for drug delivery
Lu, Y., Zhang, E., Yang, J., & Cao, Z. (2018) · Nano Research · doi:10.1007/s12274-018-2152-3 · Cited by 530 · see citing works
Kim, J., Eygeris, Y., Gupta, M., & Sahay, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.014 · Cited by 514 · see citing works
The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
Izci, M., Maksoudian, C., Manshian, B. B., & Soenen, S. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00779 · Cited by 506 · see citing works
Multifunctional polymeric micelles for delivery of drugs and siRNA
Jhaveri, A. M., & Torchilin, V. P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00077 · Cited by 466 · see citing works
Nanomedicine scale-up technologies: feasibilities and challenges
Paliwal, R., Babu, R. J., & Palakurthi, S. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0177-9 · Cited by 466 · see citing works
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
Lobatto, M. E., Fuster, V., Fayad, Z. A., & Mulder, W. J. M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3578 · Cited by 423 · see citing works
Qiao, L., Hu, S., Huang, K., Su, T., Li, Z., Vandergriff, A., Cores, J., Dinh, P.-U., Allen, T., Shen, D., et al. (2020) · Theranostics · doi:10.7150/thno.39434 · Cited by 404 · see citing works
Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles
Arvizo, R. R., Miranda, O. R., Moyano, D. F., Walden, C. A., Giri, K., Bhattacharya, R., Robertson, J. D., Rotello, V. M., Reid, J. M., & Mukherjee, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024374 · Cited by 403 · see citing works
Stimulus responsive nanogels for drug delivery
Zha, L., Banik, B., & Alexis, F. (2011) · Soft Matter · doi:10.1039/c0sm01307b · Cited by 391 · see citing works
Stimuli‐responsive nanotherapeutics for precision drug delivery and cancer therapy
Qiao, Y., Wan, J., Zhou, L., Ma, W., Yang, Y., Luo, W., Yu, Z., & Wang, H. (2019) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1527 · Cited by 332 · see citing works
Evers, M. J. W., Kulkarni, J. A., van der Meel, R., Cullis, P. R., Vader, P., & Schiffelers, R. M. (2018) · Small Methods · doi:10.1002/smtd.201700375 · Cited by 332 · see citing works
Wuttke, S., Lismont, M., Escudero, A., Rungtaweevoranit, B., & Parak, W. J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.025 · Cited by 286 · see citing works
Visualization of the Cellular Uptake and Trafficking of DNA Origami Nanostructures in Cancer Cells
Wang, P., Rahman, M. A., Zhao, Z., Weiss, K., Zhang, C., Chen, Z., Hurwitz, S. J., Chen, Z. G., Shin, D. M., & Ke, Y. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b09024 · Cited by 269 · see citing works
Folate-decorated nanogels for targeted therapy of ovarian cancer
Nukolova, N. V., Oberoi, H. S., Cohen, S. M., Kabanov, A. V., & Bronich, T. K. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.006 · Cited by 223 · see citing works
Physicochemical characterization of drug nanocarriers
Berbel Manaia, E., Paiva Abuçafy, M., Chiari-Andréo, B. G., Lallo Silva, B., Oshiro-Júnior, J. A., & Chiavacci, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s133832 · Cited by 207 · see citing works
Brown, T. D., Habibi, N., Wu, D., Lahann, J., & Mitragotri, S. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00743 · Cited by 182 · see citing works
Huang, B.-W., & Gao, J.-Q. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.005 · Cited by 174 · see citing works
Sun, R., Liu, Y., Li, S.-Y., Shen, S., Du, X.-J., Xu, C.-F., Cao, Z.-T., Bao, Y., Zhu, Y.-H., Li, Y.-P., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.018 · Cited by 172 · see citing works
Recent Advances in Nanomicelles Delivery Systems.
Tawfik, S. M., Azizov, S., Elmasry, M. R., Sharipov, M., & Lee, Y.-I. (2020) · Nanomaterials · doi:10.3390/nano11010070 · Cited by 156 · see citing works
“Nevertheless, liposomes application and lipid-based drug delivery systems have been narrowed due to attained drug resistance and poor targeting [98,99].”
BackgroundYu, Y., Chen, C.-K., Law, W.-C., Weinheimer, E., Sengupta, S., Prasad, P. N., & Cheng, C. (2014) · Biomacromolecules · doi:10.1021/bm401471p · Cited by 134 · see citing works
Zhong, D., Zhang, D., Xie, T., & Zhou, M. (2020) · Small · doi:10.1002/smll.202000819 · Cited by 132 · see citing works
Iron oxide-loaded nanotheranostics: major obstacles to in vivo studies and clinical translation
Schleich, N., Danhier, F., & Préat, V. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.024 · Cited by 124 · see citing works
Liver fibrosis resolution: from molecular mechanisms to therapeutic opportunities
Pei, Q., Yi, Q., & Tang, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119671 · Cited by 121 · see citing works
Drug releasing nanoplatforms activated by alternating magnetic fields
Mertz, D., Sandre, O., & Bégin-Colin, S. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.02.025 · Cited by 119 · see citing works
Nanocosmetics and Nanomedicines
(2011) · doi:10.1007/978-3-642-19792-5 · Cited by 116 · see citing works
Shiraishi, K., Kawano, K., Maitani, Y., Aoshi, T., Ishii, K. J., Sanada, Y., Mochizuki, S., Sakurai, K., & Yokoyama, M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.010 · Cited by 87 · see citing works
Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy
Muntimadugu, E., Kommineni, N., & Khan, W. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.010 · Cited by 82 · see citing works
Maiti, C., Parida, S., Kayal, S., Maiti, S., Mandal, M., & Dhara, D. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b18245 · Cited by 75 · see citing works
Callari, M., De Souza, P. L., Rawal, A., & Stenzel, M. H. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201701471 · Cited by 68 · see citing works
LHRH-targeted nanogels as a delivery system for cisplatin to ovarian cancer
Nukolova, N. V., Oberoi, H. S., Zhao, Y., Chekhonin, V. P., Kabanov, A. V., & Bronich, T. K. (2013) · Molecular Pharmaceutics · doi:10.1021/mp4003688 · Cited by 63 · see citing works
Lee, S.-Y., Tyler, J. Y., Kim, S., Park, K., & Cheng, J.-X. (2013) · Molecular Pharmaceutics · doi:10.1021/mp4003333 · Cited by 59 · see citing works
Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.
Singh, A. V., Khare, M., Gade, W. N., & Zamboni, P. (2012) · Autoimmune Diseases · doi:10.1155/2012/160830 · Cited by 58 · see citing works
Zhang, Y., Li, P., Pan, H., Liu, L., Ji, M., Sheng, N., Wang, C., Cai, L., & Ma, Y. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.023 · Cited by 56 · see citing works
Ghumman, S. A., Mahmood, A., Noreen, S., Rana, M., Hameed, H., Ijaz, B., Hasan, S., Aslam, A., & ur Rehman, M. F. (2022) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2022.103811 · Cited by 54 · see citing works
De Simone, U., Roccio, M., Gribaldo, L., Spinillo, A., Caloni, F., & Coccini, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071993 · Cited by 55 · see citing works
Yang, F., Zhang, M., He, W., Chen, P., Cai, X., Yang, L., Gu, N., & Wu, J. (2011) · Small · doi:10.1002/smll.201002185 · Cited by 51 · see citing works
Ghumman, S. A., Noreen, S., & tul Muntaha, S. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.03.181 · Cited by 42 · see citing works
Applications of biosensing atomic force microscopy in monitoring drug and nanoparticle delivery
Lamprecht, C., Hinterdorfer, P., & Ebner, A. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.917078 · Cited by 46 · see citing works
Ghumman, S. A., Bashir, S., Noreen, S., Khan, A. M., & Malik, M. Z. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.08.100 · Cited by 39 · see citing works
Ebenezer, O., Comoglio, P., Wong, G. K.-S., & Tuszynski, J. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044019 · Cited by 39 · see citing works
Novel siRNA delivery strategy: a new "strand" in CNS translational medicine?
Gherardini, L., Bardi, G., Gennaro, M., & Pizzorusso, T. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1310-8 · Cited by 28 · see citing works
Gupta, A., Kaur, C. D., Saraf, S., & Saraf, S. (2017) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2016.1147581 · Cited by 27 · see citing works
Smith, D. J., Leal, L. G., Mitragotri, S., & Shell, M. S. (2018) · Journal of Physics D: Applied Physics · doi:10.1088/1361-6463/aacac9 · Cited by 23 · see citing works
- Authors
- Petros, R. A., & DeSimone, J. M.
- Affiliations
- University of North Texas (US)
- University of North Carolina at Chapel Hill (US)
- ORCID
- DeSimone, Joseph M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2010-07-09
- Volume
- 9
- Issue
- 8
- Pages
- 615-627
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1975088956
- Cited by
- 3,651
- References
- 176
- Citations by year
- 2026: 93 · 2025: 134 · 2024: 172 · 2023: 171 · 2022: 204 · 2021: 214 · 2020: 272 · 2019: 274 · 2018: 270 · 2017: 356 · 2016: 315 · 2015: 331 · 2014: 278 · 2013: 240 · 2012: 197
- FWCI
- 8.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01gm059299-10)
- National Cancer Institute (U54CA119343)
- National Institute of General Medical Sciences (P01 GM-059299)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- nanoparticles, nanotherapeutics, targeted drug delivery, nanoparticle size, nanoparticle morphology, surface properties, species interactions, biological barriers
- MeSH terms
- Pharmaceutical Preparations, Humans, Particle Size, Surface Properties, Drug Design, Drug Delivery Systems, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review